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Summary 
Molecular mimicry between viral antigens and host proteins was often suggested to be involved 
in induction of autoimmune diseases. In type 1 diabetes where pancreatic 13 cells are destroyed 
by autoimmune phenomena, a linear sequence homology between a major autoantigen, gluta- 
mate decarboxylase (GAD), and the 2C protein of coxsackie B4 was identified.  In addition,  a 
sequence homology between GAD and the mycobacterial heat shock protein 60 was described 
and the suggestions were made that molecular mimicry between GAD, coxsackievirus B4-2C 
protein,  and/or heat shock protein 60 (hsp60) may be actively involved in an autoimmune reac- 
tion towards the pancreatic/g-cells. Our group was the first to isolate human monoclonal autoan- 
tibodies to GAD (MICA 1-6) from a patient with newly diagnosed type I diabetes. The MICA 
allowed a detailed characterization of the diabetes associated self-epitopes in GAD and represent 
a set of GAD autoantibodies present in sera from patients with type I diabetes. Using deletion 
mutants of GAD we demonstrated that the regions of GAD covering the homology sequences 
to coxsackievirus B4 and to the hsp60 were absolutely required for binding of the MICA to 
GAD. We now designed an antibody-based analysis to ask whether molecular mimicry between 
GAD and coxsackie B4-2C or hsp60 is relevant in type 1 diabetes. Since part of the MICA recog- 
nize conformational epitopes, they allow to test for conformational molecular mimicry in viruses 
that have been incriminated in the development of type I diabetes. Our data reveal no crossreac- 
tivity between the diabetes associated GAD epitopes defined by the MICA and hsp60, rubel- 
lavirus, cytomegalovirus, and coxsackie B1-B6 virus antigens. Neither coxsackie B4-specific anti- 
bodies in sera  from normal individuals nor GAD-positive sera from patients with type 1 diabetes 
indicated a crossreactivity between coxsackie B4-2C and GAD. Although the regions in GAD 
homologous to coxsackie B4-2C and hsp60 represented parts of GAD indispensible for binding 
of diabetes associated autoantibodies they did not mediate a crossreactivity of autoantibodies be- 
tween GAD and these two proteins.  No evidence for molecular mimicry between GAD and 
a whole panel of foreign antigens was detected by autoantibodies  in type 1 diabetes. 
M 
olecular mimicry  between epitopes common to micro- 
. bial antigens and host proteins has often been impli- 
cated in induction of autoimmune diseases. Epitopes similar 
enough to crossreact but different enough to break immuno- 
logic tolerance are believed to induce a spreading of the im- 
mune response from foreign to self-antigens. Although the 
microbial agent might be cleared, crossreactive antibodies or 
T cells, once mounted, would continue to assault the host 
(1). Sequence homologies between a whole panel of poten- 
tial autoantigens and viral antigens as well as heat shock pro- 
teins (hsp) were identified in sequence alignment studies and 
a role for molecular mimicry  was suggested in the pathogen- 
esis of the corresponding autoimmune diseases (2, 3). The 
finding of sequence homology  is, however, no direct evidence 
for biologically active molecular mimicry. Crossreactive an- 
tibodies and/or T lymphocytes must be detected in an auto- 
immune disease  before molecular mimicry  might be established 
as etiological mechanism. Animal models like experimental 
allergic encephalomyelitis demonstrated induction of autoim- 
mune disease by molecular mimicry effects (4). 
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where pancreatic B cells are destroyed by an autoimmune pro- 
cess, many unrelated viruses have been implicated in the in- 
duction of the disease (5). Only in children with congenital 
rubella syndrome has a clear correlation between virus infec- 
tion and the high incidence of IDDM emerged (6). Recent 
findings related the high frequency of IDDM in individuals 
with  congenital  rubella  syndrome  to  molecular  mimicry 
effects,  since a mouse monoclonal antibody revealed cross- 
reactivity between a rubella virus capsid protein and a 52-kD 
islet antigen (7). A major, well-characterized autoantigen in 
type 1 diabetes is the enzyme glutamate decarboxylase (GAD) 
(8) which exists in two forms, GADss and GAD67, only one 
of which, GAD6s, is expressed in human islets (9). GAD is 
recognized by autoantibodies as well as autoreactive T  cells 
(10,  11). Recently, Kaufman et al.  (12) reported a sequence 
homology between GAD6s and the 2C protein of coxsack- 
ievirus B4 (CB4) and Jones et al.  (3) described a sequence 
homology of GADss to the mycobacterial and  the human 
hsp60 (Fig.  1 A).  This raised the question whether molec- 
ular mimicry between GAD6s and these proteins is actively 
involved in induction  of IDDM. 
We recently derived human monoclonal autoantibodies to 
GAD6s (MICA 1-6) from a patient  with newly diagnosed 
IDDM, which allowed a detailed characterization of diabetes 
associated epitopes in GAD65 (13, 14). In studies with dele- 
tion mutants  of GAD6s,  the regions of GAD covering the 
homology sequences to CD4 were absolutely required for 
binding  of MICA  1,  3,  4,  and  6.  Although  the  NH2- 
terminal amino acids 1-244 could be removed from the GAD 
molecule without affecting binding of the MICA, the removal 
of an additional 50 amino acids, which included the homology 
region to CB4, prevented binding of MICA 1, 3, 4, and 6, 
and of all GAD-positive IDDM sera tested with this GAD 
deletion mutant (Fig.  1 B). The homology region of hsp60 
was  required  for  a binding  of MICA  1,  2,  and  3  to  the 
GAD65 molecule (14).  Although MICA 1, 3, 4, and 6 rec- 
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Figure  1.  Homology  of human GADs5 with the 2C protein of cox- 
sackie B4 and with human hsp60. (A) Sequence homology regions of 
GAD65 and coxsackievirus  B4-2C and GADrs and hsp60 are aligned. Iden- 
tical positions  are marked by an asterisk and conservative  amino acid changes 
by a minus sign. (B) The homology regions are indicated in a linearized 
plot of the ~ll-length GAD65 molecule. Core sequences  of GAD that are 
required for recognition of GAD65 by the individual MICA are indicated. 
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ognized  conformational  epitopes,  the  linear  sequence ho- 
mology region may provide a crucial part of the epitope. Since 
the MICA epitopes represent a set of diabetes associated epi- 
topes, these antibodies provide a unique tool to investigate 
the  existence  of molecular  mimicry  between  GAD6s  and 
proteins of CD4 or hsp60. In addition,  for the first time in 
humans, the MICA allow complex viral antigens to be probed 
for conformational molecular mimicry effects with GADrs, 
that may escape detection in sequence alignment studies. We 
here analyzed a panel of viruses previously implicated in the 
development of IDDM for molecular mimicry with diabetes- 
associated GAD6s epitopes and studied in greater detail the 
possible  crossreactivity  of CB4-2C  and  GADr5  epitopes 
using GAD-positive sera from patients with IDDM and CB4- 
positive sera from normal individuals. Our data give no evi- 
dence for a crossreactivity between GAD65 and the CB4-2C 
protein on the antibody level  Neither hsp60 nor viral an- 
tigens of rubdlavirus,  cytomegalovirus, and coxsackievirus 
B1-B6 displayed molecular mimicry to the diabetes-specific 
GAD65 epitopes defined by the MICA. 
Materials and Methods 
Viruses and Cell Lines.  The vero, HeLa, and HEL cell lines were 
obtained from the American Type Culture Collection (Rockville, 
MD) and Sf9 cells from Invitrogen (San Diego, CA). The GMK 
cell line and the picomaviruses used in this study have been de- 
scribed before (15). Coxsackieviruses and respective titers were: B1 
(P. O. Dalldorf)  10  s's TCIDs0/ml, B2 (Ohio 1) 10  ss TCIDs0/ml, 
B3 (Nancy) 10  TM TCIDs0/ml, B4 (Nc~-l-[sp]) 10  ss TCIDso/ml., B5 
(Faulkner) 10  s7 TCIDs0/ml,  B6 (1-51-21) 106.9 TCIDs0/ml.  The 
viruses were propagated on GMK cells (16) and harvested for an- 
tigen preparation after 24 h by repeated freezing and thawing fol- 
lowed by ultrasonification on ice 3  x  for 15 s. Cell debris was re- 
moved by low speed centrifugation and infectivity titers were assayed 
by endpoint titration on GMK cells and/or by plaque assay. Unin- 
fected GMK cells processed in parallel served as control  antigen. 
Cytomegalovirus was an isolate from a patient who received bone 
marrow transplantation.  Virus was grown in HEL cells and har- 
vested by Dounce homogenization of the cells after cytopathic effects 
became visible. Cell debris was removed by centrifugation at 3000 g 
for 10 min. Infectivity titer was 3  x  104 TCIDs0/ml. Uninfected 
cells processed in parallel served as control  antigens.  Kubellavi- 
rus  antigen  was purchased  from  Behringwerke  AG (Marburg, 
Germany). 
Antibodies.  The MICA were derived from a patient with IDDM 
as described (13). They were of the IgG class and recognized at 
least three distinct epitopes specific for GAD6s (13). MICA 2 rec- 
ognized a linear epitope in GAD that was rare in the sera of pa- 
tients with IDDM, whereas MICA 1, 3, 4, and 6 recognized con- 
formational epitopes similar to those detected in GAD-positive sera 
from patients with IDDM (14). Mouse anti-hsp60 antibody II C 
8 ascites was obtained from T. Gillis (Marshall University School 
of Medicine, Huntington,  WV), the CB4-specific mouse mono- 
clonal antibody M1 was produced by one of us (17), and rabbit 
anti-2C antibody by C. Hohenadl  (Max-Planck-Institute  of Bio- 
chemistry, Martinsried,  Germany) (18). 
Patients Sera and Test  for CB4 Antibodies.  Sera  from 42 normal 
individuals, 22 healthy schoolchildren, and 15 newly diagnosed pa- 
tients with IDDM were obtained with informed consent.  CB4- 
specific IgM responses were detected by an #-antibody capture 
ELISA technique employing CB4 antigens and monospecific  mouse 
Molecular Mimicry and Type I Diabetes antisera as previously  described (19). Neutralizing antibodies to CB4 
were tested by a microtechnique in GMK cells as described (20). 
Preparation  of  Mycobacterial  hsp60,  hsp60 of Mycobacterium  bovis 
BCG was expressed in Escherichia  coli  M1546 from phsmid pRIB1300 
as described (21). The protein was purified by anion-exchange  chro- 
matography (21). 
Preparation of GAD6s.  The  human  recombinant  GAD6s se- 
quence was cloned into a baculovirus expression vector and recom- 
binant virus isolated as described (22). A detergent solubilized mem- 
brane fraction of GAD6s expressing Sf9 cells and mock infected 
Sf9 cells was  prepared according to (10). 
Iramunoprecipitation  Assay.  2  ￿  106 Sf9 cells were infected by 
recombinant baculovirus expressing  human GAD6s. 40 h after in- 
fection cells were labeled  for 4 h with  100/~Ci [3SS]methionine. 
CB4-proteins were labeled  4 h  after infection of 6  x  107 HeLa 
cells with 3.6  x  109 plaque forming Units of CB4 by incubation 
of the  cells  with  150  #Ci  [sSS]methionine  in  methionine-ffee 
modified Eagle's medium. After washing cells were lysed and ex- 
tracts prepared as described above for unlabeled GAD6s. Samples 
of cytoplasmic extracts of infected HeLa cells or solubilized mem- 
brane fractions of Sf9 cells expressing GAD were precleared by in- 
cubation with 25/A CB4-negative pool serum.  To include CB4 
antibodies of the IgM class in our analysis, 25/~1 test serum was 
incubated over night with the precleared extract and the immune 
complexes were precipitated using protein A-Sepharose in a mix- 
ture with protein A-Sepharose coated with a goat anti-human IgM- 
specific antibody (1:1, 2 h,  4~  The immune complexes were 
washed in 100 mM Tris, 500 mM LiC1, 1% NP-40, 0.5% mercap- 
toethanol, and bound antigen was eluted by addition of 62 mM 
Tris/HC1, pH 6.8, 2% SDS 5% mercaptoethanol, 0.01% brom- 
phenolblue  and  subjected  to  polyacrylamid gel  electrophoresis. 
Bound protein was  detected after fluorography. 
Immunoblotting and Western Blotting.  Virus  antigens,  GAD6s 
(0.63 mg/ml) and the appropriate controls were tested pure and 
in dilutions of 1:20 and 1:50. 50 #1 of each extract were spotted 
on polyvinyldiene difluoride (PVDF) membranes  (Immobilon; Mil- 
lipore Corp., Bedford, MA) using a slot blot apparatus  (Schleicher 
& Schuell Inc., Keene, NH). Proteins separated on polyacrylamide 
gels were transfered to PVDF by semidry blotting. Blotting mem- 
branes were stained  by for 2 h with MICA culture supernatants 
(2 #g/ml), human monoclonal IgG control antibody (2 #g/ml), 
rabbit anti-2C antibody (1:100), mouse anti-hsp60 II C  8 ascites 
(1:400) or supernatant of the CB4-specific mouse monoclonal anti- 
body M1  (17) (undiluted). 
Results 
Reactivity of  MICA 1-6 with Viral Antigens.  Viral antigens 
from coxsackie B1-B6,  from cytomegalovirus,  herpes  sim- 
plex virus and rubeUavirus were tested for their reactivity with 
the individual MICA in an immunoblotting assay using the 
native antigens. Extracts of uninfected host cells, GAD6s ex- 
pressed  in  baculovirus  permissive  Sf9  cells  and  wild-type 
baculovirus infected Sf9 cells expressing no GAD were in- 
cluded as controls (Fig. 2). Whereas spotted GAD65 was de- 
tected by all six MICA,  neither the viral antigens  nor the 
controls were recognized by MICA  1-6. CB4 antigens were 
specifically stained by the CB4-specific mouse  monoclonal 
antibody M1  used as  a  positive control. 
Reactivity  of MICA  I-6 with hsp60.  Different dilutions 
of a  GAD6s  extract  and  of purified  hsp60  from M.  bovis 
BCG were analyzed in a slot blot assay (Fig. 3). The MICA 
did  not  crossreact  with  the  hsp60  suggesting  that  the 
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Figure  2.  Reactivity of MICA 1-6 with viral antigens. Viral antigens 
of  coxsackie  B1-B6, cytomegalovims,  mbellavirus,  and herpes  simplex  virus 
were spotted on membrane sheets and tested for their reactivity with the 
MICA. MICA 4 was selected  as example  for the typical reactivity of all 
MICA that stained solely  GAD. The anti-coxsackievims  B4 (CB4)-specific 
control antibody M1 reacted  with the CB4 antigen only and an unrelated 
human monoclonal IgG antibody revealed  no reactivity with the tested 
virus antigens. Positions of the antigens: la, CB1; 2a, CB2; 3a, CB3; 4a, 
CB4; 5a, CB5; 6a, CB6; lb, 2b, 3b, mock infected GMK; 4b, GAD6s; 
5b, Sf9 control extract; lc, Cytomegalovirus;  2c, mock infected  HEL; 3c, 
mock infected Vero; 4c herpes simplex virus, 5c rubellavirus. 
GAD6s region of amino  acids  520-534,  which  is homolo- 
gous to hsp60,  is not directly involved in the epitope recog- 
nition of MICA  1, 2,  and 3  which required this region of 
GAD for binding. Alternatively, the homology between the 
two proteins is too weak to induce crossreactivity by an au- 
toantibody isolated from  a patient  with  type  1  diabetes. 
Reactivity  of CB4-positive Sera with GAD6s.  We further 
analyzed whether CB4 infection in humans induced antibodies 
crossreactive with GAD65.15 sera positive for CB4 IgM an- 
tibodies in the ELISA and  15 CB4 IgM-negative sera from 
normal individuals, 22 sera from normal individuals with neu- 
tralizing antibodies to CB4, and 20 normal sera negative for 
neutralizing CB4 antibodies were tested for their reactivity 
with  GAD  in  an  immunoprecipitation  assay  using  3sS- 
labeled GAD6s  expressed in  a  baculovirus  system.  A  com- 
bined analysis of IgM and IgG antibodies was performed for 
the CB4 IgM-positive  sera.  The results  are summarized  in 
Table  1.  No  reactivity with  GAD6s  was  observed with  all 
sera.  When  seven CB4-IgM-positive  and eight CB4-IgM- 
negative sera from patients  with IDDM  were tested in the 
same  assay,  no  correlation  was  found  between  the  CB4- 
positivity and the GAD-reactivity of these sera.  CB4 infec- 
tion, therefore, did not induce antibodies crossreactive with 
GAD6s and GAD antibodies appeared independent of posi- 
tivity for CB4  in  patients  with  IDDM. 
Figure 3.  Reactivity  of  MICA 
1-6 with hsp60 ofM. bov/s  BCG. 
GAD6s  was  expressed  in 
baculovirus SD cells and a deter- 
gent solubilized  membrane  fraction 
of  the cells  (5/~g total protein/ml), 
was  spotted on membranes to- 
gether with purified  hsp60 (2 #g/ 
ml). For each antigen three dilu- 
tions were applied (from top to 
bottom: pure, 1:5, and 1:25). Lane 
a was stained  by an unrelated  human monodonal antibody,  lane b  by MICA 
2, lane c by the anti-hsp60-specific  mouse monoclonal antibody IIC8, and 
lane dby an unrelated mouse monoclonal antibody. All six MICA showed 
identical results. 
Richter et al.  Brief Definitive Report Table  1.  Correlation  of Anti-coxsackie B4 (CB4)-reactive 
Antibodies with Anti-GAD-reactive  Antibodies in Normal 
Individuals and Patients with IDDM 
No. of 
Individuals  sera tested  GAD6spositive 
Normal 
CB4  IgM positive*  15  0 
CB4  IgM negative  15  0 
CB4 NA positive*  22  0 
CB4  NA negative  20  0 
IDDM 
CB4  IgM positive  8  3 
CB4  IgM negative  7  4 
* Anti-CB4 IgM antibodies were  determined  by ELISA. 
* NA, neutralizing antibodies were determined by a microtechnique  in 
GMK cells. 
Reactivity of GADTositive Sera with CB4-2C.  MICA 1-6 
and 10 GAD-positive sera from 10 newly diagnosed patients 
with IDDM as well as 10 sera from normal individuals posi- 
tive for neutralizing CB4 antibodies and 2 individuals nega- 
tive for CB4 were analyzed for their reactivity with  CB4- 
2C.  HeLa  cells  were  infected  with  CB4  and  labeled  by 
[35S]methionine  incorporation.  Extracts  of  CB4  infected 
HeLa cells were immunoprecipitated with the MICA or the 
individual sera after preclearing with a CB4-negative serum. 
Precipitation of viral antigens was detected after separation 
of the samples by PAGE. No reactivity of the MICA with 
CB4 antigens was detected (Fig.  4 A) concordant with the 
results presented in Fig.  2.  In contrast,  all  sera recognized 
a whole panel of bands irrespective of their positivity in the 
CB4-specific ELISA or the neutralizing  test.  To determine 
whether 2C was among the proteins precipitated by the sera, 
the immunoprecipitates  were subjected to Western blotting 
and  stained with  an  anti-2C  rabbit  serum raised  against  a 
20-amino acid consensus epitope of the 2C protein of cox- 
sackie  B viruses (18).  The results are shown in Fig.  4. 3 of 
the 10 GAD-positive sera from patients with IDDM revealed 
a reactivity with  the 2C protein  as well as 3  of 10 GAD- 
negative sera tested from normal individuals. The frequency 
of anti-2C antibodies was, therefore, identical in GAD-positive 
individuals with IDDM and GAD-negative normal individ- 
uals. This suggests no correlation of an anti-2C response with 
autoreactivity to GAD in patients developing type 1 diabetes. 
Discussion 
Since the isolation of CB4 particles from islets of a patient 
who died with acute onset of IDDM and the induction of 
diabetes in mice infected with these particles, CB4 infections 
were frequently claimed to be correlated with IDDM. In non- 
human primates and some mouse strains CB4 infections pro- 
Figure 4.  Reactivity with coxsackievirus  B4-2C. (21) [3sS]methionine- 
labeled extracts of  HeLa cells infected with coxsackievirus B4 were immu- 
noprecipitated by (a) anti-2C-specific rabbit serum, (b) anti-CB4-specific 
mouse monoclonal antibody M1, (c) rabbit control serum, (d) MICA 1, 
(e) MICA 2, (]) MICA 4, and (g) MICA 6, and samples were analyzed 
by PAGE  and fluorography. The arrows indicate the 2ABC precursor pro- 
tein of 2C (65 kD) and the protein 2C (37 kD), which were both precipi- 
tated by the 2C-specific rabbit serum. M1 recognized the viral structural 
protein Vp1 and precursors of VP1 (b). The MICA did not recognize any 
of the proteins. (B) HeLa cells infected with coxsackievirus B4 were im- 
munoprecipitated by 10 sera from GAD-negative normal individuals and 
10 sera from GAD-positive patients at onset of type 1 diabetes. The samples 
were subjected to Western blotting and stained for detection of coxsackie 
B4 2C by a rabbit serum raised against a linear epitope in 2C. The 2C 
protein  in the extract used for immunoprecipitation (a) is indicated by 
an arrow. Results of four GAD-negative normal sera (b-e) and four GAD- 
positive diabetic sera (f-0 are shown. 
duced transient  diabetes (23,  24), but in humans  the large 
number of serological and epidemiological studies revealed 
no clear picture of an implication of CB4 infection in IDDM 
(reviewed in 5).  After identification  of the 64-kD islet an- 
tigen as GAD (8) a sequence homology between this major 
autoantigen  in  diabetes  and  the  2C  protein  of CB4  was 
identified (12). Molecular mimicry effects between GAD and 
CB4, therefore, were suggested to play a role in islet cell de- 
struction and development of IDDM. We isolated six diabetes- 
associated GAD-specific human monodonal autoantibodies, 
four of which required the CB4 homology region in GAD65 
for a binding  to the GAD6s molecule (14).  Now we dem- 
onstrate that these antibodies do not crossreact with native 
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linear  sequence  homology region  shared  between  GADds 
and CB4-C2, although being an important part of the con- 
formational epitopes of MICA 1, 3, 4, and 6 did not mediate 
a crossreactivity between both proteins. 
The coxsackievirus 2C protein is a nonstructural virus pro- 
tein that  is produced by the infected cell did not incorpo- 
rated in the infectious particle itself. 2C may have a function 
in the replication of viral RNA (25) and is highly conserved 
among coxsackieviruses B1-B6 (26). Sera from normal indi- 
viduals irrespective of positivity for neutralizing  anti-CB4 
antibodies or anti-CB4-IgM-ELISA antibodies all recognized 
CB4 virus proteins.  The fact that the two sera negative for 
antibodies to CB1-CB6 still recognized a pattern of CB4 an- 
tigens may be due to the presence of antibodies to other picor- 
naviruses that are known to be highly crossreactive to cox- 
sackie antigens (16,  27). Reactivity to the viral protein 2C 
was detected in 30% of CB4-positive normal individuals by 
Western blotting.  GAD-positive sera of patients with type 
I diabetes revealed the same frequency of an anti-2C response 
like GAD-negative normal individuals.  This argues against 
a crossreactivity between CB4-2C and GAD6s progressing 
to a development of type 1 diabetes in susceptible individ- 
uals. Neither the CB4-specific antibodies in sera of CB4 posi- 
tive individuals  nor GAD antibodies in IDDM,  therefore, 
provided any evidence that tolerance to the linear epitope of 
GAD which is homologous to CB4-2C was broken.  This 
suggests no molecular mimicry effects between GAD65 and 
the CB4-2C protein in the humoral immune response of type 
1 diabetes. 
Controversial data exist about the implication of hsps in 
the development of IDDM (28, 29). One group reported that 
hsp60 was among the antigens  recognized by the diabetes 
associated 64-kD  antibodies  (28).  Other  groups,  however, 
clearly demonstrated that 64-kD antibodies recognize GAD 
(8)  and detected no anti-hsp60  antibodies in sera from pa- 
tients with  IDDM (29).  In spite of the reported  sequence 
similarity between GAD and hsp60 (Fig.  1) (3) we demon- 
strated herein that the observed sequence homology did not 
induce crossreactivity by a set of human monoclonal autoan- 
tibodies. In an animal model of IDDM,  the NOD mouse, 
T cell clones reactive to mycobacterial hsp60 have been shown 
to induce insulitis and hyperglycemia (30). The T cell-reac- 
tive peptides in hsp60 were confined to amino acids 437-474, 
and were, therefore, different from the homology region ob- 
served between hsp60 and GAD65.  Neither  the T  cell epi- 
topes in hsp60 characterized in the NOD mouse system nor 
the typical set of diabetes associated autoantibodies in humans 
tested here, therefore, suggest any relevance for molecular mim- 
icry effects  between hsp60 and  GADds in  type 1 diabetes. 
The humoral antibody response in humans tested here sug- 
gests  no  relevance  for molecular  mimicry  effects between 
GADds,  the  CB4-2C  protein,  hsp60,  and  other  virus  an- 
tigens which have been suggested to be involved in induc- 
tion of type I diabetes. No data are available about possible 
T  cell-mediated molecular mimicry to GAD in humans  as 
T  cell reactive epitopes in GAD remain  to be determined. 
In NOD mice the late activation of T  cells to the CB4 ho- 
mologous region in GAD provides evidence against the hy- 
pothesis that molecular mimicry between CB4 and GAD6s 
triggers the autoimmune response on the T cell level in this 
animal model of IDDM (31). We agree with others that di- 
rect destruction  of islet cells by viruses (32),  upregulation 
of MHC class I molecules (33,  34),  induction  of an inap- 
propriate MHC class II expression on islets (35),  enhance- 
ment of cytokine production in the periphery of islets after 
virus infections (33, 34), or a combination of these mecha- 
nisms may be the relevant factors leading to IDDM in a crit- 
ical immunogenetic background rather than molecular mim- 
icry effects between viral antigens  and GAD65. 
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